Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Expands Biomarker Collaboration with Mitsubishi Tanabe

NEW YORK (GenomeWeb News) – Metabolon said today that it has expanded its ongoing biomarker discovery collaboration with Mitsubishi Tanabe Pharma.
 
Research Triangle Park, NC-based Metabolon said that the new agreement will provide researchers at the Japanese firm with preferred access to Metabolon’s global biochemical profiling services. It also said that Mitsubishi Tanabe has committed several upcoming research studies to Metabolon.
 
Further terms of the alliance were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.